Clinical trial of TC-210 T CELLS in Patients with Advanced Mesothelin Expressing Cancer
Enrolling By Invitation
99 years or below
All
Phase
1
25 participants needed
1 Location
Brief description of study
Your partner is participating in a research study which is looking to determine the safety and efficacy of the drug product, TC-210 T Cells. Your partner has received theTC-210 T Cells. You are being asked to provide information to the Sponsor and your partner’s study doctor, because your partner has reported that you became pregnant from him while he was enrolled in this study. To date, no information has been collected on pregnant women whose partners have been exposed to the TC-210 T Cells. There is a risk that the study medications may affect the development of the fetus if a woman is exposed to the study medications by transfer via semen leading to pregnancy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cancer
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 833254
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu
